Emend (aprepitant) — Blue Cross Blue Shield of Alabama
Cancer chemotherapy related nausea and vomiting when receiving chemotherapy more than 7 days per month
Initial criteria
- Quantities above the program set limit will be approved when ONE of the following is met:
- • The patient has cancer chemotherapy related nausea and vomiting and the patient will be receiving chemotherapy more than 7 days per month OR
- • The prescriber has provided information supporting the use of the requested agent for the requested diagnosis and quantity
Approval duration
12 months